Renato Mastrangelo

1.6k total citations
57 papers, 1.2k citations indexed

About

Renato Mastrangelo is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, Renato Mastrangelo has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Neurology, 18 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in Renato Mastrangelo's work include Neuroblastoma Research and Treatments (25 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Acute Lymphoblastic Leukemia research (13 papers). Renato Mastrangelo is often cited by papers focused on Neuroblastoma Research and Treatments (25 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Acute Lymphoblastic Leukemia research (13 papers). Renato Mastrangelo collaborates with scholars based in Italy, United States and Malaysia. Renato Mastrangelo's co-authors include Riccardo Riccardi, Anna Lasorella, Joseph Kaplan, William Peterson, Vittoria Rufini, L Troncone, David G. Poplack, Assunta Tornesello, Wolf W. Zuelzer and Stefano Mastrangelo and has published in prestigious journals such as The Lancet, Blood and PEDIATRICS.

In The Last Decade

Renato Mastrangelo

55 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renato Mastrangelo Italy 21 415 313 265 259 238 57 1.2k
William A. Smithson United States 18 245 0.6× 656 2.1× 144 0.5× 190 0.7× 189 0.8× 37 1.6k
Carl Lenarsky United States 22 255 0.6× 389 1.2× 184 0.7× 311 1.2× 105 0.4× 54 1.9k
Kenneth B. DeSantes United States 16 374 0.9× 275 0.9× 124 0.5× 108 0.4× 175 0.7× 32 1.1k
Elvis Terci Valera Brazil 18 227 0.5× 725 2.3× 135 0.5× 368 1.4× 186 0.8× 108 1.4k
Kirsten van Lom Netherlands 25 153 0.4× 539 1.7× 124 0.5× 427 1.6× 134 0.6× 47 1.5k
L. S. Lashford United Kingdom 23 622 1.5× 687 2.2× 66 0.2× 950 3.7× 235 1.0× 47 1.9k
Kwan Y. Wong United States 15 1.7k 4.1× 1.1k 3.5× 212 0.8× 219 0.8× 593 2.5× 30 2.5k
George C. Bobustuc United States 13 365 0.9× 193 0.6× 58 0.2× 221 0.9× 96 0.4× 24 983
Nalini Jayaprakash United States 16 267 0.6× 226 0.7× 155 0.6× 82 0.3× 49 0.2× 21 825
Fred G. Behm United States 23 260 0.6× 675 2.2× 1.3k 4.8× 270 1.0× 122 0.5× 38 2.3k

Countries citing papers authored by Renato Mastrangelo

Since Specialization
Citations

This map shows the geographic impact of Renato Mastrangelo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renato Mastrangelo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renato Mastrangelo more than expected).

Fields of papers citing papers by Renato Mastrangelo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renato Mastrangelo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renato Mastrangelo. The network helps show where Renato Mastrangelo may publish in the future.

Co-authorship network of co-authors of Renato Mastrangelo

This figure shows the co-authorship network connecting the top 25 collaborators of Renato Mastrangelo. A scholar is included among the top collaborators of Renato Mastrangelo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renato Mastrangelo. Renato Mastrangelo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mastrangelo, Stefano, et al.. (2000). Radioresistant sensitization of neuroblastoma by cisplatin?. Medical and Pediatric Oncology. 35(1). 77–79. 6 indexed citations
2.
Mastrangelo, Renato, Assunta Tornesello, & Stefano Mastrangelo. (1998). Position paper: Role of131I-metaiodobenzylguanidine in the treatment of neuroblastoma. Medical and Pediatric Oncology. 31(1). 22–26. 21 indexed citations
3.
Servidei, Tiziana, Daniela Meco, Cristiano Ferlini, et al.. (1998). Antitumor activity of BBR 3464 in neuroblastoma (NB) cell lines. 1 indexed citations
4.
Mastrangelo, Renato, Assunta Tornesello, Anna Lasorella, et al.. (1997). Optimal use of the 131-I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma. Journal of Neuro-Oncology. 31(1-2). 153–158. 23 indexed citations
5.
Mastrangelo, Renato, Assunta Tornesello, Riccardo Riccardi, et al.. (1995). A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin. European Journal of Cancer. 31(4). 606–611. 33 indexed citations
6.
Zollino, Marcella, Maurizio Genuardi, Assunta Tornesello, et al.. (1995). Constitutional trisomy 8 and myelodysplasia: Report of a case and review of the literature. Leukemia Research. 19(10). 733–736. 19 indexed citations
7.
Mastrangelo, Renato, Anna Lasorella, Antonio Iavarone, et al.. (1993). Critical observations on neuroblastoma treatment with 131‐I‐metaiodobenzylguanidine at diagnosis. Medical and Pediatric Oncology. 21(6). 411–415. 13 indexed citations
8.
Tornesello, Assunta, Cesare Colosimo, Antonio Iavarone, Riccardo Riccardi, & Renato Mastrangelo. (1993). Granulocytic sarcoma. Medical and Pediatric Oncology. 21(2). 122–126. 3 indexed citations
9.
Troncone, L, Vittoria Rufini, Riccardo Riccardi, Anna Lasorella, & Renato Mastrangelo. (1992). The use of [131I]metaiodobenzylguanidine in the treatment of neuroblastoma after conventional therapy.. PubMed. 35(4). 232–6. 12 indexed citations
10.
Riccardi, Riccardo, et al.. (1991). Cranial irradiation and cerebrospinal fluid levels of 6-mercaptopurine in children with acute leukemia. Medical Oncology and Tumor Pharmacotherapy. 8(2). 95–98. 2 indexed citations
11.
Iavarone, Antonio, Tiziana Servidei, Riccardo Riccardi, Anna Lasorella, & Renato Mastrangelo. (1991). Specific uptake of 125-I-metaiodobenzylguanidine in human neuroblastoma cell lines is associated with the neuroblastic cell type.. PubMed. 366. 447–54. 2 indexed citations
12.
Troncone, L, Vittoria Rufini, Paolo Montemaggi, et al.. (1990). The diagnostic and therapeutic utility of radioiodinated metaiodobenzy1guanidine (MIBG). European Journal of Nuclear Medicine and Molecular Imaging. 16(4-6). 325–335. 90 indexed citations
13.
Mastrangelo, Renato. (1986). The problem of “staging” in childhood acute lymphoblastic leukemia: A review. Medical and Pediatric Oncology. 14(3). 121–123. 1 indexed citations
14.
Mastrangelo, Renato, et al.. (1984). Prediction of clinical response to glucocorticoids in children with acute lymphoblastic leukemia. 1(1). 33–36. 6 indexed citations
15.
Mastrangelo, Renato, David G. Poplack, & Riccardo Riccardi. (1983). Central nervous system leukemia : prevention and treatment. 12 indexed citations
16.
Mastrangelo, Renato, David G. Poplack, & Riccardo Riccardi. (1983). Central Nervous System Leukemia. PubMed. 75(3). 367–71. 9 indexed citations
17.
Iacobelli, Stefano, Franco O. Ranelletti, Paola Longo, Riccardo Riccardi, & Renato Mastrangelo. (1978). Discrepancies between in vivo and in vitro effects of glucorticoids in myelomonocytic leukemic cells with steroid receptors.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(11 Pt 2). 4257–62. 24 indexed citations
18.
Romagnoli, C, Guillaume Polidori, Maria Pia Foschini, et al.. (1975). Agar in the management of hyperbilirubinaemia in the premature baby.. Archives of Disease in Childhood. 50(3). 202–204. 21 indexed citations
19.
Mastrangelo, Renato, et al.. (1974). Spontaneous leukocyte oscillation during blastic crisis of chronic myeloid leukemia. Cancer. 33(6). 1610–1614. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William A. Smithson Breakdown of academic impact, for papers by Carl Lenarsky Breakdown of academic impact, for papers by Kenneth B. DeSantes Breakdown of academic impact, for papers by Elvis Terci Valera Breakdown of academic impact, for papers by Kirsten van Lom Breakdown of academic impact, for papers by L. S. Lashford Breakdown of academic impact, for papers by Kwan Y. Wong Breakdown of academic impact, for papers by George C. Bobustuc Breakdown of academic impact, for papers by Nalini Jayaprakash Breakdown of academic impact, for papers by Fred G. Behm
Rankless by CCL
2026